Neuropilin 1: A Novel Entry Factor for SARS-CoV-2 Infection and a Potential Therapeutic Target
Endeshaw Chekol Abebe,1 Teklie Mengie Ayele,2 Zelalem Tilahun Muche,3 Tadesse Asmamaw Dejenie4 1Department of Medical Biochemistry, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia; 2Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Eth...
Guardado en:
Autores principales: | Chekol Abebe E, Mengie Ayele T, Tilahun Muche Z, Asmamaw Dejenie T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cfae77aa74634f528d01f2655df8fc29 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
por: Dharmendra Kumar Yadav, et al.
Publicado: (2021) -
Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step
por: Shiu-Wan Chan, et al.
Publicado: (2021) -
Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains
por: Enya Qing, et al.
Publicado: (2021) -
Sulphated polysaccharides from seaweeds as potential entry inhibitors and vaccine adjuvants against SARS-CoV-2 RBD spike protein: a computational approach
por: Mountasser Douma, et al.
Publicado: (2021) -
SARS-CoV-2 spike protein: Site-specific breakpoints for the development of COVID-19 vaccines
por: Palaniyandi Velusamy, et al.
Publicado: (2021)